Stocks and Investing Stocks and Investing
Wed, August 21, 2024
Tue, August 20, 2024

Tiago Fauth Maintained (UTHR) at Buy with Increased Target to $380 on, Aug 20th, 2024


Published on 2024-10-28 13:46:44 - WOPRAI, Tiago Fauth
  Print publication without navigation


Tiago Fauth of Wells Fargo, Maintained "United Therapeutics Corporation" (UTHR) at Buy with Increased Target from $350 to $380 on, Aug 20th, 2024.

Tiago has made no other calls on UTHR in the last 4 months.



There are 8 other peers that have a rating on UTHR. Out of the 8 peers that are also analyzing UTHR, 2 agree with Tiago's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Terence Flynn of "Morgan Stanley" Downgraded from Buy to Hold and Increased Target to $321 on, Thursday, July 11th, 2024
  • Chris Shibutani of "Goldman Sachs" Maintained at Hold with Increased Target to $240 on, Friday, May 3rd, 2024


These are the ratings of the 6 analyists that currently disagree with Tiago


  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $400 on, Thursday, August 1st, 2024
  • Greg Harrison of "B of A Securities" Maintained at Sell with Decreased Target to $280 on, Thursday, August 1st, 2024
  • Joseph Thome of "TD Cowen" Maintained at Strong Buy with Increased Target to $350 on, Thursday, July 11th, 2024
  • Ashwani Verma of "UBS" Maintained at Strong Buy with Increased Target to $370 on, Monday, July 8th, 2024
  • Jessica Fye of "JP Morgan" Maintained at Buy with Increased Target to $300 on, Tuesday, May 21st, 2024
  • Hartaj Singh of "Oppenheimer" Maintained at Buy with Increased Target to $400 on, Thursday, May 2nd, 2024
Contributing Sources